Hunan Qianjin Xiangjiang Pharmaceutical

Hunan Qianjin Xiangjiang Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs. As a core subsidiary of the publicly traded Zhuzhou Qianjin Pharmaceutical Group, the company focuses on high-demand therapeutic areas including cardiovascular health, antiviral treatments, and gastrointestinal medicine. Its product portfolio features several widely used generic medications such as Entecavir for Hepatitis B and Rosuvastatin for cholesterol management. The company operates large-scale GMP-certified manufacturing facilities in Zhuzhou, Hunan, capable of producing various oral solid dosage forms. It is recognized for its integration of R&D with industrial-scale production to provide affordable healthcare solutions in the Chinese domestic market.